文献速递主动脉疾病

血管质量倡议中主动脉腔内干预术后卒中发生率

Stroke rate after endovascular aortic interventions in the Society for Vascular Surgery Vascular Quality Initiative.
PubMed 文献 · J Vasc Surg · 2020-04-02

基于血管质量倡议2011-2019年数据,择期EVAR术后院内卒中率0.1%,复杂EVAR为0.9%,TEVAR为2.9%。EVAR中瘤径>6.5mm和使用近端延伸袖套与卒中独立相关;复杂EVAR中手臂入路与卒中风险升高8.4倍相关;TEVAR中更近端锚定区与卒中风险增高相关。

要点

  • 择期EVAR后卒中罕见,但复杂EVAR和TEVAR后明显增高
  • EVAR中近端延伸袖套与卒中风险独立相关
  • 复杂EVAR中手臂入路与卒中风险升高8.4倍相关

核心结论

  • 择期EVAR后卒中罕见,但复杂EVAR和TEVAR后卒中率显著更高。

研究设计与样本

  • 回顾性队列研究,纳入VQI数据库2011-2019年择期EVAR 41540例、复杂EVAR 1371例、TEVAR 4600例。

主要发现

  • 院内卒中率:EVAR 0.1%,复杂EVAR 0.9%,TEVAR 2.9%。
  • EVAR中动脉瘤直径>6.5mm(OR 1.7,95%CI 1.1-2.7,P=.03)和使用近端延伸袖套(OR 3.3,95%CI 1.4-7.9,P<.01)与卒中独立相关。
  • 复杂EVAR中手臂入路与卒中风险升高8.4倍相关(95%CI 1.7-41,P<.01)。
  • TEVAR中更近端锚定区与卒中风险增高相关:zone 2 OR 3.8(95%CI 1.8-8.2),zone 0/1 OR 6.3(95%CI 2.8-14)。

关键数值与推荐

  • EVAR中动脉瘤直径>6.5mm与卒中独立相关。
  • 复杂EVAR中手臂入路与卒中风险升高8.4倍相关(95%CI 1.7-41)。
  • TEVAR中zone 0/1锚定区与卒中风险增高相关(OR 6.3,95%CI 2.8-14)。

临床怎么用

  • 临床决策时应将复杂EVAR和TEVAR中卒中风险纳入考量。
  • 复杂EVAR中应关注手臂入路与卒中的强关联,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The stroke rate after endovascular aneurysm repair (EVAR), particularly complex EVAR such as fenestrated EVAR (FEVAR) and chimney EVAR (chEVAR), is not well defined. Whereas stroke is a well-established risk of thoracic endovascular aortic repair (TEVAR), the impact of procedural characteristics on stroke remains unclear. Therefore, we characterized the risk of stroke after endovascular aortic interventions in the Vascular Quality Initiative database and identified procedural characteristics associated with stroke. METHODS: We performed a retrospective cohort study of patients undergoing infrarenal EVAR, complex EVAR, and TEVAR within the Vascular Quality Initiative between 2011 and 2019. Complex EVAR included FEVAR (with either a Food and Drug Administration-approved custom-manufactured device or physician-modified endovascular graft) and chEVAR. We excluded emergent procedures. The primary outcome was in-hospital stroke. We used multivariable logistic regression to identify procedural characteristics associated with stroke. RESULTS: We identified 41,540 EVARs, 1371 complex EVARs, and 4600 TEVARs. The in-hospital stroke rate was 0.1% after EVAR, 0.9% after complex EVAR, and 2.9% after TEVAR. In patients undergoing EVAR, aneurysm diameter >6.5 mm (odds ratio [OR], 1.7; 95% confidence interval [CI], 1.1-2.7; P = .03) and use of a proximal extension cuff (OR, 3.3; 95% CI, 1.4-7.9; P < .01) were independently associated with stroke. Among complex EVARs, stroke rate was 0.7% after FEVAR with a custom-manufactured device, 0.4% after FEVAR with a physician-modified endovascular graft, and 2.1% after chEVAR (P = .08). In multivariable analysis, arm access was associated with 8.4-fold higher odds of stroke (95% CI, 1.7-41; P < .01). Whereas chEVAR was associated with higher odds of stroke in crude analysis, this association did not persist after adjustment for arm access (OR, 1.0; 95% CI, 0.2-4.4; P = .99). In patients undergoing TEVAR, more proximal landing zones were associated with higher risk of stroke compared with zone 4/5 (zone 3: OR, 2.0 [95% CI, 0.9-4.2]; zone 2: OR, 3.8 [95% CI, 1.8-8.2]; zone 0/1: OR, 6.3 [95% CI, 2.8-14]). In terms of procedural characteristics, any involvement of the left subclavian artery was associated with stroke (bypass: OR, 2.5 [95% CI, 1.5-4.0]; stent: OR, 2.7 [95% CI, 0.9-8.5]; covered or occluded: OR, 2.5 [95% CI, 1.5-4.1]). CONCLUSIONS: Stroke, although rare after elective EVAR, is substantially more common after complex EVAR and TEVAR. Increasing procedural complexity in complex EVAR and TEVAR is associated with a higher stroke rate, a risk that should be factored into clinical decision-making. The strong association between stroke and upper extremity access during complex EVAR is alarming and warrants further study.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Swerdlow NJ, Liang P, Li C, et al. Stroke rate after endovascular aortic interventions in the Society for Vascular Surgery Vascular Quality Initiative. J Vasc Surg. 2020. PMID: 32249044. doi:10.1016/j.jvs.2020.02.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。